Applied Materials is the world's leading supplier of the ultra-sophisticated equipment used in factories that make semiconductors. Will a global glut in chips clobber the stock? Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
"Sin" stock Philip Morris boasts heavenly dividends. But now, this Big Tobacco stalwart is transitioning to reduced-risk products. Can it succeed? Read More
Comcast is in acquisition mode and rapidly embracing advanced technologies. But as it seeks new avenues for growth, will this multi-media colossus get stretched too thin? Read More
Merck has been a money-making machine for decades, but it faces growing competition and patent expirations. Will this drug giant prevail? Read More
Home Depot is a DJIA component and steady dividend payer. But do economic headwinds and a cooling housing sector pose threats to this retail icon and its payout? Read More
Pfizer is a growth-and-income stock found in many retirement portfolios. But is the competition from biotech "disruptors" getting too hot for this Big Pharma stalwart? Read More
Chevron is poised to gain from rising crude prices, but the energy sector remains volatile. Can this "super major" overcome the industry's uncertainties? Read More
As the largest health insurer in the U.S., UnitedHealth Group is poised to greatly benefit from booming health care expenditures. But do proposed government policy changes threaten the stock? Read More
Health services giant Johnson & Johnson has been a reliable growth-and-income stock for years, but can it overcome the scandal about its allegedly carcinogenic talcum powder? Read More
General Motors has proven itself a survivor, emerging from the federal government bailout in competitive shape. But disruptive technology and economic storm clouds now threaten this Detroit icon. Read More